AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2013
Sep 20, 2013
29864_dirs_2013-09-20_f7af4f94-e4df-4efe-bd36-833bbdaad4ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2013-09-18
Reporting Person: BOGER JOSHUA S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-09-18 | Common Stock | M | 1400 | $9.07 | Acquired | 340295 | Direct |
| 2013-09-18 | Common Stock | S | 1000 | $77.26 | Disposed | 339295 | Direct |
| 2013-09-18 | Common Stock | S | 400 | $77.84 | Disposed | 338895 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-09-18 | Employee Stock Option (right to buy) | $9.07 | M | 1400 | Disposed | 2013-12-10 | Common Stock (1400) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 300000 | Indirect |
| Common Stock | 13286 | Indirect |
Footnotes
F1: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F2: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3: Open market sales reported on this line occurred at a weighted average price of $77.26 (range $76.69 to $77.64).
F4: Open market sales reported on this line occurred at a weighted average price of $77.84 (range $77.68 to $78.07).
F5: Common stock held in grantor retained annuity trusts.
F6: Fully vested.